Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

NCT07334574

Conditions: B-cell Non-Hodgkin's Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Not yet recruiting

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

NCT07335094

Conditions: B Lymphoblastic Leukemia/Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

NCT07320534

Conditions: Acute Lymphoblastic Leukemia, Agranulocytosis, Cytopenia, +16 more
Locations: RSUP dr Sardjito Sleman, DI Yogyakarta, Indonesia

View Trial Details

Not yet recruiting

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07322159

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

NCT07319481

Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, China

View Trial Details

Not yet recruiting

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

NCT07316920

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Not yet recruiting

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

NCT07316907

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +13 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Not yet recruiting

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

NCT07310186

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma

NCT07276230

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Caregivers of Patients With Multiple Myeloma, +13 more
Locations: Hématologie clinique - Pitié-Salpêtrière Hospital (APHP) Paris, France

View Trial Details

Not yet recruiting

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

NCT07301138

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions